Researchers identified several antibodies to the nucleocapsid protein from a convalescent COVID-19 patient. Tests found some can inhibit complement hyperactivation and could potentially lead to new ...
In a recent study posted to the bioRxiv* pre-print server, researchers investigated the complement component 1q (C1q) binding and subsequent complement activation by neutralizing antibodies (nAbs) ...
Pembrolizumab in gastrointestinal (GI) malignancies with defective DNA mismatch repair (dMMR): A single institution experience. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I.
UPDATE // November 5, 2020 The original text has been changed to clarify that Adaptive Technologies is based in Seattle, Washington. Ominous headlines have been common in recent months declaring that ...
Increasingly new insights and emerging treatments based on the complement system have encouraged Creative Biolabs, a leading CRO in complement therapeutics discovery, to enrich services customized for ...
Dysfunction of the complement system plays an important role in the pathogenesis of renal diseases. Complement inhibitors, such as C5 inhibitors, have shown efficacy in clinical trials, but may no be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback